Federal Funding Opportunities

Browse federal grant and contract opportunities from Grants.gov and SAM.gov

Clear
Grants.gov HHS-FDA Forecasted
Improving Predictability of Food-Drug and Drug-Drug Interaction Risks by Utilizing In Vitro Simulated Gastrointestinal Dissolution …

Food and Drug Administration

The purpose of this funding opportunity is to examine the utility of an in vitro simulated gastrointestinal (GI) dissolution model for the assessment of in vitro performance of amorphous solid disper…

Funding Range
$250,000.00 – $500,000.00
Total Funding
N/A
No close date
View Details
Grants.gov HHS-FDA Forecasted
Evaluating the Cutaneous Pharmacokinetics of Topical Drug Products Using Pharmacokinetic Tomography (U01 Clinical Trial Required)

Food and Drug Administration

The purpose of this funding opportunity is to support the research and development necessary to advance non-invasive (e.g., quantitative tomography-based) technologies, including the development of a…

Funding Range
$250,000.00 – $250,000.00
Total Funding
N/A
No close date
View Details
Grants.gov HHS-FDA Forecasted
Synthesis and Biological Activity Assessment of Different Diastereomers in siRNA Drug LEQVIO (Inclisiran) (U01) Clinical …

Food and Drug Administration

The purpose of this research is to systematically evaluate the diastereomeric composition of LEQVIO (Inclisiran), an FDA-approved, N-acetyl galactosamine (GalNAc)-conjugated siRNA drug, and to unders…

Funding Range
$300,000.00 – $300,000.00
Total Funding
N/A
No close date
View Details
Grants.gov HHS-FDA Forecasted
Utilizing Real-World Data and Algorithmic Analyses to Assess Post-Market Clinical Outcomes in Patients Switching Amongst …

Food and Drug Administration

Complex generic drug products represent an increasing share of the generic marketplace and may have distinct user interface differences compared to reference listed drug (RLD) products. A modernized …

Funding Range
$300,000.00 – $300,000.00
Total Funding
N/A
No close date
View Details
Grants.gov HHS-NIH11 Posted
Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional)

National Institutes of Health

The National Institutes of Health (NIH) hereby notifies NIH award recipients that funds may be available for revision applications to support the expansion of existing projects and/or programs within…

Funding Range
Not specified
Total Funding
N/A
110 days left
View Details
Grants.gov HHS-FDA Forecasted
Identification and Evaluation of Possible Approaches to Addressing Nitrosamine Impurities in Drugs (U01)

Food and Drug Administration

The Food and Drug Administration's (FDA), Center for Drug Evaluation and Research (CDER), Office of New Drugs (OND), is announcing this Funding Opportunity Announcement (FOA) for a Cooperative Agreem…

Funding Range
$350,000.00 – $350,000.00
Total Funding
N/A
No close date
View Details
Grants.gov HHS-FDA Forecasted
Flexible Funding Model-Infrastructure Development and Maintenance for State Manufactured Food Regulatory Programs (U2F) Clinical Trials …

Food and Drug Administration

The intended outcome of this Notice of Funding Opportunity (NOFO) is to advance efforts for a nationally Integrated Food Safety System (IFSS) by supporting Manufactured Food Regulatory Program Standa…

Funding Range
$340,000.00 – $1,285,000.00
Total Funding
N/A
No close date
View Details
Grants.gov HHS-FDA Forecasted
Identification of Drug-related and Formulation-Related Factors that Result in Alcohol Dose Dumping of Modified Release …

Food and Drug Administration

Modified release (MR) oral drug products are considered to have a high risk for alcohol dose dumping (ADD) because they contain large quantities of drug(s), designed to release over a prolonged perio…

Funding Range
$250,000.00 – $250,000.00
Total Funding
N/A
No close date
View Details
Grants.gov HHS-FDA Forecasted
Developing PBPK Model-Based Mechanistic IVIVCs for Long Acting Injectable Suspensions and Implants (U01) Clinical Trial …

Food and Drug Administration

The objective of this research proposal is to develop physiologically based pharmacokinetic (PBPK) model-based mechanistic in vitro in vivo correlations (IVIVCs) for two major types of long acting in…

Funding Range
Up to $300,000.00
Total Funding
$600,000.00
No close date
View Details
Grants.gov HHS-FDA Forecasted
Integrating Machine Learning with Computational Fluid Dynamics Models of Orally Inhaled Drug Products (U01) Clinical …

Food and Drug Administration

Computational fluid dynamics (CFD) has played a crucial role in providing an alternative bioequivalence (BE) approach for generic orally inhaled drug products (OIDPs), in addition to comparative clin…

Funding Range
Not specified
Total Funding
$600,000.00
No close date
View Details
Grants.gov HHS-NIH11 Posted
NHLBI Program Project Applications (P01 Clinical Trials Optional)

National Institutes of Health

The National Heart, Lung, and Blood Institute (NHLBI) Program Project Grant (P01) supports research related to fundamental processes and diseases of the heart, blood and lymphatic vessels, lungs, and…

Funding Range
Not specified
Total Funding
N/A
50 days left
View Details
Grants.gov DOT-FAA-FAA COE-AJFE Posted
Center of Excellence for Alternative Jet Fuels and Environment

FAA-COE-AJFE

The opportunity for the Federal Aviation Administration (FAA) Center of Excellence for Alternative Jet Fuel and Environment (AJFE) was awarded in 2013 to the ASCENT cooperative aviation research orga…

Funding Range
$1.00 – $20,000,000.00
Total Funding
N/A
55 days left
View Details